Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Immunoassay Analyzers Market Research Report Information By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), By Application (Infectious Diseases, Autoimmune Diseases, AIDS), By End-User (Hospitals) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032


ID: MRFR/MED/0694-HCR | 80 Pages | Author: Kinjoll Dey| April 2024

Global Immunoassay Analyzers Market Overview


The Immunoassay Analyzers Market Size was valued at USD 1.1 billion in 2022. The Immunoassay Analyzers market is projected to grow from USD1.1594 Billion in 2023 to USD 1.765867 billion by 2032, exhibitinga compound annual growth rate (CAGR) of 5.40% during the forecast period (2023 - 2032). Increased prevalence of infectious immunological or metabolic diseases, rising demand for advanced diagnostic devices, and recent trends of automation and integration are the key market drivers enhancing market growth.Immunoassay Analyzers Market


Source Secondary Research, Primary Research, MRFR Database, and Analyst Review


Immunoassay Analyzers Market Trends



  • The increasing incidence of chronic and infectious diseases is driving the market growth.


The burden of chronic diseases, the massive infection rate, and the COVID-19 pandemic have necessitated using immune-diagnostic assays for containment and management. Immunoassay tests are an essential diagnostic tool that offers reliable and low-cost detection of pathogens or target molecules. These tests are used to diagnose both highly prevalent and chronic diseases. On a  scale, immunoassays have become the frontline diagnostics for detecting several pathogens and pathophysiological conditions. The increasing demand for the early-stage diagnosis of disease conditions using immunoassay products is another major factor driving the market growth. ly, the number of diabetics is expected to grow from 643 million in 2030 to 783 million by 2045. Diabetes resulted in 6.7 million deaths worldwide in 2021, while 541 million people are estimated to be at risk of developing diabetes. This factor drives the market CAGR.


The WHO underlined the concern of HIV, which has claimed over 33 million lives; an estimated 38 million people have HIV infections. Similarly, The International Agency for Research on Cancer and GLOBOCAN estimated 19.3 million new cases of cancer and 10.0 million deaths in 2020. Breast cancer dominates this estimate with 2.3 million new cases, followed by lung, colorectal, prostate, and stomach cancer.


Additionally, the major factors contributing to the growth of the clinical immunoassay analyzer market include the increasing prevalence of chronic & infectious diseases, adoption of advanced immunoassay tests, increasing aging population, development in R&D activities to enhance the product, and high demand for next-generation immunodiagnostics. However, high costs and limited reimbursements restrain market growth. The introduction of paper-based electrochemical immunoassay devices and increasing healthcare infrastructure provide lucrative Immunoassay Analyzers market revenue during the forecast period.


Immunoassay Analyzers Market Segment Insights


Immunoassay Analyzers Instruments Insights


Based on instruments, the Immunoassay Analyzers market segmentation includes immunofluorescence, chemiluminescence, ELISA, and radioimmunoassay application. The ELISA segment dominated the market due to rapid tests, ELISpot, western blotting, radioimmunoassay, and other technologies. The large share of this technology segment can primarily be attributed to the increasing use of ELISA tests in cancer diagnosis, infectious diseases detection, and therapeutic drug level monitoring.


Immunoassay Analyzers Application Insights


Based on Application, the Immunoassay Analyzers market segmentation includes infectious diseases, autoimmune diseases, and AIDS. The infectious diseases segment dominated the market due to the rising prevalence of infectious diseases and the increase in product launches catering to infectious disease diagnosis to drive the segment's growth.


Figure 1 Immunoassay Analyzers Market, by Application, 2022&2032 (USD billion)Immunoassay Analyzers Market, by Application, 2022&2032


Source Secondary Research, Primary Research, MRFR Database, and Analyst Review


Immunoassay Analyzers End-User Insights


The Immunoassay Analyzers market segmentation, based on end-user, includes hospitals. The hospital segment dominated the market because the large share can be attributed to the high demand for immunoassay products in hospitals with increased hospitalizations due to chronic and infectious diseases. The increasing number of corporate hospital chains further boosts market demand for automated immunoassay analyzers.


Immunoassay Analyzers Regional Insights


By region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American immunoassay analyzers market will dominate this market due to the commercial availability of products with advanced technologies. These products' high adoption rate will boost the Region's market growth.


Further, the major countries studied in the market report are The U.S., Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 2 IMMUNOASSAY ANALYZERS MARKET SHARE BY REGION 2022 (%)IMMUNOASSAY ANALYZERS MARKET SHARE BY REGION 2022


Source Secondary Research, Primary Research, MRFR Database, and Analyst Review


Europe Immunoassay Analyzers market accounts for the second-largest market share due to sophisticated healthcare infrastructure, high disposable income, increasing healthcare expenditure, and growing awareness about the early diagnosis of diseases. Further, the German Immunoassay Analyzers market held the largest market share, and the UK Immunoassay Analyzers market was the fastest-growing market in the European Region.


The Asia-Pacific Immunoassay Analyzers Market is expected to grow at the fastest CAGR from 2023 to 2032. This is due tothe rapidly growing number of manufacturing facilities in the Region is boosting the growth in this Region. Moreover, China’s Immunoassay Analyzers market held the largest market share, and the Indian Immunoassay Analyzers market was the fastest-growing market in the Asia-Pacific region.


Immunoassay Analyzers Key Market Players& Competitive Insights


Leading market players are investing heavily in research and development to expand their product lines, which will help the Immunoassay Analyzers market grow even more. Market participants are also undertaking various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. The immunoassay analyzers industry must offer cost-effective items to expand and survive in a more competitive and rising market climate.


Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the Immunoassay Analyzers industry to benefit clients and increase the market sector. In recent years, the Immunoassay Analyzers industry has offered some of the most significant advantages to medicine. Major players in the Immunoassay Analyzers market, including F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), The Binding Site Group Ltd. (UK), Immunodiagnostic Systems (UK), Merck KGaA (US), Olympus Corporation (Japan), Nova Century Scientific, Inc. (US), Thermo Fisher Scientific (US), DiaSorin S.p.A. (Italy) and Randox Laboratories Ltd. (UK)., and others, are attempting to increase market demand by investing in research and development operations.

  • Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.Roche received Emergency Use Authorization from the FDA for the Cobas SARS-CoV- 2 Duo for use on the fully automated Cobas 6800/8800 Systems.
  • Beckman Coulter Inc. is a Danaher Corporation company that develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical testing. It operates in two industries Diagnostics and Life Sciences.Beckman Coulter agreed with Quidel Corporation to gain rights for the BNP assay's manufacturing, distribution, and sales by Quidel for Beckman Coulter analyzers.


    Key Companies in the immunoassay analyzers market include



    • Hoffmann-La Roche Ltd. (Switzerland)

    • Siemens Ltd. (Germany)

    • Abbott (US)

    • Beckman Coulter Inc. (US)

    • Ortho Clinical Diagnostics (US)

    • bioMérieux Private Limited (France)

    • Biokit S.A (Spain)

    • The Binding Site Group Ltd. (UK)

    • Immunodiagnostic Systems (UK)

    • Merck KGaA (US)

    • Olympus Corporation (Japan)

    • Nova Century Scientific Inc. (US)

    • Thermo Fisher Scientific (US)

    • DiaSorin S.p.A. (Italy)

    • Randox Laboratories Ltd. (UK)


    Immunoassay Analyzers Industry Developments


    June 2022 Roche received Emergency Use Authorization from the FDA for the Cobas SARS-CoV- 2 Duo for use on the fully automated Cobas 6800/8800 Systems.


    July 2021 Beckman Coulter agreed with Quidel Corporation to gain rights for the BNP assay's manufacturing, distribution, and sales by Quidel for Beckman Coulter analyzers.


    December 2020 Abbott received US FDA EUA for its BinaxNOW COVID-19 Ag Card Rapid Test.


    Immunoassay Analyzers Market Segmentation


    Immunoassay analyzers Instruments Outlook



    Immunoassay analyzers Application Outlook



    Immunoassay analyzers End-User Outlook



    • End-User


    Immunoassay Analyzers Regional Outlook




    • North America

      • US

      • Canada




    • Europe

      • Germany

      • France

      • UK

      • Italy

      • Spain

      • Rest of Europe




    • Asia-Pacific

      • China

      • Japan

      • India

      • Australia

      • South Korea

      • Australia

      • Rest of Asia-Pacific




    • Rest of the World

      • Middle East

      • Africa

      • Latin America



    Immunoassay Analyzers Report Scope
    Report Attribute/Metric Details
    Market Size2022 USD 1.1billion
    Market Size 2023 USD 1.1594billion
    Market Size2032 USD 1.76586billion
    Compound Annual Growth Rate (CAGR) 5.40%(2023-2032)
    Base Year 2022
    Market Forecast Period 2023-2032
    Historical Data 2018- 2022
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Instruments, Application, End-User, and Region
    Geographies Covered North America, Europe, AsiaPacific, and the Rest of the World
    Countries Covered The U.S., Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), The Binding Site Group Ltd. (UK), Immunodiagnostic Systems (UK)
    Key Market Opportunities New product launches and R&D Amongst major key Players
    Key Market Dynamics Increasing prevalence of different infectious, immunological, or metabolic diseases Increasing demand for advanced diagnostic devices and recent trends of automation and integration


    Frequently Asked Questions (FAQ) :

    The Immunoassay Analyzers market size was valued at USD 1.1Billion in 2022.

    The market is projected to grow at a CAGR of 5.40% during the forecast period, 2023-2032.

    North America had the largest share of the market

    The key players in the market are F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Ltd. (Germany), Abbott (US), Beckman Coulter, Inc. (US), Ortho Clinical Diagnostics (US), bioMérieux Private Limited (France), Biokit S.A (Spain), The Binding Site Group Ltd. (UK), Immunodiagnostic Systems (UK).

    The Infectious DiseasesImmunoassay Analyzers category dominated the market in 2022.

    Hospitals had the largest share of the market.

    Leading companies partner with us for data-driven Insights
    client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
    Kindly complete the form below to receive a free sample of this Report
    Please fill in Business Email for Quick Response

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Request Free Sample
    Purchase Option
    Single User $ 4,950
    Multiuser License $ 5,950
    Enterprise User $ 7,250
    Compare Licenses
    Tailored for You
    • Dedicated Research on any specifics segment or region.
    • Focused Research on specific players in the market.
    • Custom Report based only on your requirements.
    • Flexibility to add or subtract any chapter in the study.
    • Historic data from 2014 and forecasts outlook till 2040.
    • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
    • Provide cross segmentation in applicable scenario/markets.
    Ask for Customization